Gene transfer of c-met confers protection against d-galactosamine/ lipopolysaccharide-induced acute liver failure

Digestive Diseases and Sciences

Volumn 57, Issue 4, 2012, Pages 925-934

  Zhu, Chuanlong ^a   Li, Yuwen ^a   Li, Wenting ^a   Wu, Quan ^a   Gao, Rentao ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

C met; Gene therapy; Hepatocyte growth factor; Liver failure; Liver regeneration

Indexed keywords

COMPLEMENTARY DNA; GALACTOSAMINE; LIPOPOLYSACCHARIDE; PLASMID DNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ACUTE LIVER FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KAPLAN MEIER METHOD; LIVER CELL; LIVER REGENERATION; NICK END LABELING; NONHUMAN; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CRICETINAE; CRICETULUS; FEMALE; GALACTOSAMINE; GENETIC THERAPY; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; LIPOPOLYSACCHARIDES; LIVER FAILURE, ACUTE; LIVER REGENERATION; OVARY; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, WISTAR; TRANSFECTION;

EID: 84864067265     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2052-4     Document Type: Article

References (36)

1. McKenzie TJ, Lillegard JB, Nyberg SL. Artificial and bioartificial liver support. Semin Liver Dis. 2008;28:210-217.
2. Riordan SM, Williams R. Perspectives on liver failure: past and future. Semin Liver Dis. 2008;28:137-141.
3. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179-1197.
4. Han DW. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol. 2002;8:961-965.
5. Liu M, Chan CW, McGilvray I, Ning Q, Levy GA. Fulminant viral hepatitis: molecular and cellular basis, and clinical implications. Expert Rev Mol Med. 2001;2001:1-19.
6. Naoumov NV, Eddleston AL. Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus. Gut. 1994;35:1013-1017.
7. Wu Z, Han M, Chen T, Yan W, Ning Q. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 2010; 30:782-794.
8. Zhu CL, Yan WM, Zhu F, et al. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol. 2005;11:6936-6940.
9. Rutherford A, Chung RT. Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin Liver Dis. 2008;28: 167-174.
10. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog. 1992;3:27-54.
11. Nakamura T. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration. Princess Takamatsu Symp. 1994;24:195-213.
12. Schmidt C, Bladt F, Goedecke S, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 1995;373:699-702.
13. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA. 2004;101:4477-4482.
14. Ganschow R, Knoke A, Drews D, Burdelski M. Tissue expression of HGF, c-met, TNF[alpha], IL-6 and IL-1Ra in acute liver failure and liver cirrhosis of childhood: correlation with serum cytokines. J Pediatr Gastroenterol Nutr. 1997;24:482.
15. Mizuguchi T, Kamohara Y, Hui T, et al. Regulation of c-met expression in rats with acute hepatic failure. J Surg Res. 2001;99:385-396.
16. Ravikumar V, Shivashangari KS, Devaki T. Hepatoprotective activity of Tridax procumbens against d-galactosamine/lipopolysaccharide- induced hepatitis in rats. J Ethnopharmacol. 2005;101:55-60.
17. Higgins GM, Anderson RM. Experimental pathology of the liver.I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol. 1931;12:186-202.
18. Maruyama H, Higuchi N, Kameda S, Miyazaki J, Gejyo F. Rat liver-targeted naked plasmid DNA transfer by tail vein injection. Mol Biotechnol. 2004;26:165-172.
19. Maruyama H, Higuchi N, Nishikawa Y, et al. High-level expression of naked DNA delivered to rat liver via tail vein injection. J Gene Med. 2002;4:333-341.
20. Nowak M, Gaines GC, Rosenberg J, et al. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNFalpha and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1202-R1209.
21. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 1992;16:1227-1235.
22. Fujiwara K, Nagoshi S, Ohno A, et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology. 1993;18:1443-1449.
23. Ishii T, Sato M, Sudo K, et al. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem. 1995;117:1105-1112.
24. Roos F, Terrell TG, Godowski PJ, Chamow SM, Schwall RH. Reduction of alpha-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor. Endocrinology. 1992;131:2540-2544.
25. Kaido T, Yoshikawa A, Seto S, et al. Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats. Hepatology. 1998;28: 756-760.
26. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology. 1996;24:636-642.
27. Kosai K, Matsumoto K, Funakoshi H, Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology. 1999;30:151-159.
28. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun. 1998;244:683-690.
29. Rutherford AE, Hynan LS, Borges CB, et al. Serum apoptosis markers in acute liver failure: a pilot study. Clin Gastroenterol Hepatol. 2007;5:1477-1483.
30. D'Errico A, Fiorentino M, Ponzetto A, et al. Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does. Hepatology. 1996;24:60-64.
31. Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annu Rev Biochem. 2005;74:711-738.
32. Nguyen TH, Ferry N. Liver gene therapy: advances and hurdles. Gene Ther. 2004;11:S76-S84.
33. Zhu CL, Li YW, Gao RT. Gene therapy for acute liver failure. Curr Gene Ther. 2010;10:156-166.
34. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6:1258-1266.
35. Suda T, Liu D. Hydrodynamic gene delivery: its principles and applications. Mol Ther. 2007;15:2063-2069.
36. Ueno M, Uchiyama K, Nakamori M, et al. Adenoviral vector expressing hepatocyte growth factor promotes liver regeneration by preoperative injection: the advantages of performing selective injection to the remnant lobe. Surgery. 2007;141:511-519.